Clinical impact of carbapenems in critically ill patients with valproic acid therapy: a propensity-matched analysis

HIGHLIGHTS

• who: Shu-Chen Hsiao from the Careggi University Hospital, Italy have published the research: Clinical impact of carbapenems in critically ill patients with valproic acid therapy: A propensity-matched analysis, in the Journal: (JOURNAL)
• what: The authors found that the concomitant administration of VPA and CBPs was a risk factor compared to increased mortality (33.8 vs. 24.9%), which may be due to the increased risk of SE in the CBP group.
• how: This result is consistent with the findings in previous studies in which the in-hospital mortality rate of SE . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.